Subscriber • Opinion

We need a more proactive plan to deal with coming infectious threats

By Sarah Newton
September 8 2021 - 7:25pm
Australia needs its own mRNA vaccine production facilities. Picture: Shutterstock

Last weekend, the Biden White House announced its $US65 billion Apollo Plan. Named after the moon missions, the aim is to create a full-time centralised office with the purpose of rapidly identifying emerging threats and co-ordinating the US government's response. Importantly, $US24 billion is allocated to developing, testing and manufacturing new vaccines for a broad range of viral threats, with almost $US12 billion earmarked for developing therapeutics, and $US5 billion for diagnostic tests - with the remainder used to, among other things, build capacity for manufacturing vital supplies.



Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.